Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy—a report from the Children's Oncology Group

S. Miser, James; E. Goldsby, Robert; Chen, Zhengjia; D. Krailo, Mark; J. Tarbell, Nancy; P. Link, Michael; J.H. Fryer, Christopher; J. Pritchard, Douglas; C. Gebhardt, Mark; S. Dickman, Paul; J. Perlman, Elizabeth; A. Meyers, Paul; S. Donaldson, Sarah; G. Moore, Sheila; R. Rausen, Aaron; J. Vietti, Teresa; E. Grier, Holcombe

doi:10.1002/pbc.21233

Public

Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy—a report from the Children's Oncology Group

Published in Pediatric Blood & Cancer • Jun 21, 2007

Authors:

James S. Miser

Robert E. Goldsby

Zhengjia Chen

Abstract

Abstract Background The outcome for patients with Ewing sarcoma family of tumors (ESFTs) of bone with metastases at diagnosis remains poor despite new approaches to treatment. We evaluated whether a dose‐intensity chemotherapy regimen improved survival for patients with ESFTs of bone with metastases...

View

Paywalled

View Full Text

Generate AI Take for this paper

Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.

Generate AI Take for this paper

Discussions